Screener

Eligibility screening

AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma

Sponsored by University of FloridaStudy detailsClinicalTrials.gov

1 US site in FL

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.